BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5761073)

  • 1. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
    Wagner RH; Roberts HR; Webster WP; Shanbrom E; Brinkhous KM
    Thromb Diath Haemorrh Suppl; 1968; 35():41-8. PubMed ID: 5761073
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of and clinical experience with antihemophilic factor concentrates.
    Johnson AJ; Karpatkin MH; Newman J
    Thromb Diath Haemorrh Suppl; 1968; 35():49-59. PubMed ID: 5317364
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of aliphatic amino acid precipitated antihemophilic factor in therapy of hemophilia.
    Brinkhous KM; Wagner RH; Roberts HR; Webster WP
    Bibl Haematol; 1968; 29():1104-8. PubMed ID: 5700305
    [No Abstract]   [Full Text] [Related]  

  • 4. Prepooled cryoprecipitate for treatment of hemophilia A.
    Menitove JE; Spero JA; Richards WA; Lewis JH; Montgomery RR; Gill JC; Hasiba U; Wheeler DV; Sherwin JA; Russell-Vaskov S; Marlar RA; Maxwell NG; Aster RH
    Transfusion; 1983; 23(3):265-7. PubMed ID: 6407160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cryoprecipitation and dextran precipitation in obtaining factor VIII concentrates: results of redetecting antihemophilic globulin A in a patient].
    Kubel M; Wegner H; Liebe S
    Z Gesamte Inn Med; 1974 Mar; 29(6):236-40. PubMed ID: 4409090
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factor VIII concentrates].
    Faber JC
    Bull Soc Sci Med Grand Duche Luxemb; 1986; 123(2):27-9. PubMed ID: 3100076
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of a new glycine-precipitated antihemophilic fraction.
    Webster WP; Roberts HR; Thelin GM; Wagner RH; Brinkhous KM
    Am J Med Sci; 1965 Dec; 250(6):643-51. PubMed ID: 5846510
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor VIII (antihemophilic globulin).
    Aronson DL
    Semin Thromb Hemost; 1979; 6(1):12-27. PubMed ID: 390712
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor VIII concentrates made in the United Kingdom and the treatment of haemophilia based on studies made during 1969--72. Report of the Medical Research Council's Blood Transfusion Research Committee Working Party on the cryoprecipitate method of preparing AHF concentrates.
    Br J Haematol; 1974 Jul; 27(3):391-405. PubMed ID: 4413414
    [No Abstract]   [Full Text] [Related]  

  • 10. The potent antihemophilic globulin concentrate derived from a cold insoluble fraction of human plasma: characterization and further data on preparation and clinical trial.
    Hershgold EJ; Pool JG; Pappenhagen AR
    J Lab Clin Med; 1966 Jan; 67(1):23-32. PubMed ID: 5321736
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with plasma concentrates in hemophilia A. State Security and Health Planning Office. Expert Panel].
    Sangre (Barc); 1994 Apr; 39(2):157-61. PubMed ID: 8059299
    [No Abstract]   [Full Text] [Related]  

  • 12. A new high-potency glycine-precipitated antihemophilic factor (AHF) concentrate. Treatment of classical hemophilia and hemophilia with inhibitors.
    Brinkhous KM; Shanbrom E; Roberts HR; Webster WP; Fekete L; Wagner RH
    JAMA; 1968 Aug; 205(9):613-7. PubMed ID: 5695099
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid correction of AHF deficiency by antihemophilic factor-method four, with special reference to inhibitors.
    Shanbrom E
    Bibl Haematol; 1970; 34():52-9. PubMed ID: 5436353
    [No Abstract]   [Full Text] [Related]  

  • 14. [Technic of obtaining the antihemophilic factors VIII and IX and their clinical application].
    Triginer J; Vila M; Vicente Arangüena P
    Sangre (Barc); 1979; 24(5-C):937-41. PubMed ID: 121169
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of haemophilia A with purified factor 8 obtained from human plasma by cryoprecipitation.
    Meyer K; Eernisse JG; Veltkamp JJ; Hemker HC; Loeliger EA
    Folia Med Neerl; 1967; 10(2):49-60. PubMed ID: 6039247
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of classical hemophilia with factor 8 concentrates.
    Waterbury L; Frenkel EP
    Clin Anesth; 1968; 3():288-97. PubMed ID: 4902367
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the "in vivo" activity of factor VIII or factor IX after injection of several concentrates: practical applications].
    Allain JP
    Nouv Rev Fr Hematol; 1972; 12(2):241-9. PubMed ID: 4264617
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preparatory procedures for obtaining antihemolytic globulin (factor VIII) by the cryoprecipitation method and its various properties].
    Lopaciuk S; Naleczyńska A; Klenowska Z; Daszyński J; Pawelski S
    Pol Tyg Lek; 1969 Jun; 24(22):826-9. PubMed ID: 5802316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Modification of J.G. Pool's technic for the production of cryoprecipitates with highly concentrated antihemophilic globulin (factor 8) content. I].
    Wegner H; Bergmann A
    Z Gesamte Inn Med; 1967 Jul; 22(13):389-92. PubMed ID: 5592690
    [No Abstract]   [Full Text] [Related]  

  • 20. Freeze dried cryoprecipitate: a clinical evaluation.
    Hambley H; Davidson JF; Walker ID; Small M; Prentice CR
    J Clin Pathol; 1983 May; 36(5):574-6. PubMed ID: 6404949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.